Ocumetics Technology Corp OTC

CALGARY, ALBERTA - September 8, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that its clinical facility in Mexico City has initiated the patient recruitm...

CALGARY, ALBERTA - August 31, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. ("Ocumetics" or the "Corporation") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce the successful completion of manufacturing of its next generation solid st...

CALGARY, ALBERTA - July 9, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a developer of advanced vision restoration technologies, is pleased to provide shareholders with a corp...

CALGARY, ALBERTA - June 2, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a developer of advanced vision restoration technologies, is pleased to announce that debentureholders h...

Key Highlights - Precision molds received for manufacturing of new optimized accommodating intraocular lenses - Production and testing of next-generation lenses now underway - New lens design incorporates insights from Group One First-in-Human study ...

Key Highlights - Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements - Safety profile: Continues to meet expectations - Quality-of-life improvements: Anecdotally, all patients repor...

CALGARY, CANADA - March 31, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. ("Ocumetics" or the "Company") (TSV:V OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced that its research division, Ocumeti...